Welcome to visit Zhongnan Medical Journal Press Series journal website!

Prediction and analysis of disease burden of lip and oral cavity cancer in five Asian regions from 1990 to 2023

Published on Jun. 09, 2026Total Views: 18 timesTotal Downloads: 3 timesDownloadMobile

Author: CAO Wencong 1 GAO Kai 1 RONG Yi 1 WU Zhangjing 1 YU Yong 1, 2

Affiliation: 1. School of Public Health, Hubei University of Medicine, Shiyan 442000, Hubei Province, China 2. Center of Health Administration and Development Studies, Hubei University of Medicine, Shiyan 442000, Hubei Province, China

Keywords: Lip and oral cavity cancer Disease burden Age-period-cohort modeling Bayesian age-period-cohort modeling

DOI: 10.12173/j.issn.1004-5511.202603008

Reference: Cao WC, Gao K, Rong Y, et al. Prediction and analysis of disease burden of lip and oral cavity cancer in five Asian regions from 1990 to 2023[J]. Yixue Xinzhi Zazhi, 2026, 36(5): 541-549. DOI: 10.12173/j.issn.1004-5511.202603008.[Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Objective To analyze the disease burden of lip and oral cavity cancer (LOC) in five Asia regions (Central Asia, South Asia, Southeast Asia, East Asia, and the high-income Asia-Pacific region) from 1990 to 2023, and predict the future trends.

Methods Based on the Global Burden of Disease (GBD) 2023 database, data on mortality, incidence, prevalence, and disability-adjusted life years (DALYs) of LOC were extracted. Joinpoint regression was used to analyze trends changes, and the age-period-cohort (APC) model was employed to assess the age, period, and cohort effects. Using a Bayesian age-period-cohort (BAPC) model, with 2023 observed value as the baseline, the disease burden trends for 2024—2035 were predicted.

Results In 2023, South Asia had the heaviest LOC disease burden, ranking first in terms of age-standardized mortality rate (ASMR) (6.9/100,000), age-standardized incidence rate (ASIR) (10.72/100,000), age-standardized prevalence rate (ASPR) (31.71/100,000), and age-standardized DALY rate (ASDR) (197.22/100,000 per-son-years). In 2023, the incidence and mortality rates of LOC were higher in men than in women across all five regions, particularly in the 35-79 years age group. From 1990 to 2023, Southeast Asia experienced the largest increase in the overall disease burden of LOC, the average annual percentage change (AAPC) for ASMR, ASPR, ASIR, and ASDR were 0.46%, 1.63%, 1.04%, and 0.63%, respectively, while Central Asia showed the largest decrease in overall LOC disease burden, the AAPC for ASMR, ASPR, ASIR, and ASDR were -0.72%, 0.01%, -0.40%, and -0.87%, respectively. The APC model results indicated that the prevalence of LOC increased with age, concentrating in the population aged 60-80 years; the period-cohort effect showed that individuals from the same birth cohort have higher prevalence rates in recent years compared to the earlier years; the age-cohort effect indicated that, within the same age group, individuals born more recently had higher prevalence rates than those born earlier. The BAPC projection model indicated that the disease burden in South Asia will rise significantly by 2035 (ASMR: 5.4/100,000; ASIR: 9.7/100,000), while the disease burden in Central Asia will decline significantly (ASMR: 0.8/100,000; ASIR: 1.5/100,000).

Conclusion The disease burden of LOC continues to increase in most of Asia, with significant regional differences. South and Southeast Asia should prioritize screening high-risk populations and implementing appropriate inter-ventions against risk factors such as tobacco and alcohol use. Epidemiological improvements in Central and East Asia offer valuable reference for other regions. Future attention should be paid to rapidly increasing mortality and incidence rates in South Asia and Southeast Asia, and optimize resource allocation, and conduct in-depth investigations into epidemiological mechanisms involving lifestyle and environmental exposures to inform regional prevention and control strategies.

Full-text
Please download the PDF version to read the full text: download
References

1.Bugshan A, Farooq I. Oral squamous cell carcinoma: metastasis, potentially associated malignant disorders, etiology and recent advancements in diagnosis[J]. F1000Res, 2020, 9: 229.

2.Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263.

3.Cao W, Chen HD, Yu YW, et al. Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020[J]. Chin Med J (Engl), 2021, 134(7): 783-791.

4.Global Burden of Disease 2019 Cancer Collaboration, Kocarnik JM, Compton K, et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis for the global burden of disease study 2019[J]. JAMA On-colhttps://pubmed.ncbi.nlm.nih.gov/?term=Cancer+incidence%2C+mortality%2C+years+of+life+lost%2C+years+lived+with+disability%2C+and+disability-adjusted+life+years+for+29+cancer+groups+from+2010+to+2019%3A+a+systematic+analysis+for+the+global+burden+of+disease+study+2019, 2022, 8(3): 420-444.

5.Cunha ARD, Compton K, Xu R, et al. The global, regional, and national burden of adult lip, oral, and pharyngeal cancer in 204 countries and territories: a systematic analysis for the global burden of disease study 2019[J]. JAMA On-colhttps://pubmed.ncbi.nlm.nih.gov/37676656/, 2023, 9(10): 1401-1416.

6.Michaelsen SH, Gronhoj C, Michaelsen JH, et al. Quality of life in survivors of oropharyngeal cancer: a systematic review and Meta-analysis of 1366 patients[J]. Eur J Cancer, 2017, 78: 91-102.

7.Filho AM, Warnakulasuriya S. Epidemiology of oral cancer in South and South-East Asia: incidence and mortality[J]. Oral Dis, 2024, 30(8): 4847-4854.

8.Ribeiro-Rotta RF, Rosa EA, Milani V, et al. The cost of oral cancer: a systematic review[J]. PLoS One, 2022, 17(4): e0266346.

9.Ren ZH, Hu CY, He HR, et al. Global and regional burdens of oral cancer from 1990 to 2017: results from the global burden of disease study[J]. Cancer Commun (Lond), 2020, 40(2-3): 81-92.

10.GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990—2023: a systematic analysis for the Global Burden of Disease Study 2023[J]. Lan-cethttps://pubmed.ncbi.nlm.nih.gov/41092926/, 2025, 406(10513): 1873-1922.

11.GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancethttps://pubmed.ncbi.nlm.nih.gov/30496107/, 2018, 392(10159): 2091-2138.

12.Kim HJ, Fay MP, Feuer EJ, et al. Permutation tests for joinpoint regression with applications to cancer rates[J]. Stat Med, 2000, 19(3): 335-351.

13.Bell A. Age period cohort analysis: a review of what we should and shouldn't do[J]. Ann Hum Biol, 2020, 47(2): 208-217.

14.Fosse E, Winship C. Bounding analyses of age-period-cohort effects[J]. Demography, 2019, 56(5): 1975-2004.

15.Wu X, Du J, Li L, et al. Bayesian age-period-cohort prediction of mortality of type 2 diabetic kidney disease in China: a modeling study[J]. Front Endocrinol, 2021, 12: 767263.

16.Chen WQ, Zheng RS, Zeng HM. Bayesian age-period-cohort prediction of lung cancer incidence in China[J]. Thorac Cancer, 2011, 2(4): 149-155.

17.Prajapati N, Chaudhari CC, Dixit GT, et al. Tobacco and betel nut use among school going adolescents of government high school of Himmatnagar city, Gujarat, India: a cross sectional study[J]. Int J Contemp Pediatr, 2017, 4(2): 306-309.

18.Gul F, Khan AA, Kazmi SNH, et al. Vaping, an emerging public health concern in South Asia: a short communication[J]. Ann Med Surg (Lond), 2023, 85(5): 2270-2272.

19.Suyamud B, Pan X, Yu Y, et al. First-of-its-kind: nationwide Meta-analysis of microplastic pollution and risk assessment in Thailand[J]. Chemosphere, 2024, 364: 143041.

20.Batsaikhan U, Dabrowski M. Central Asia—twenty-five years after the breakup of the USSR[J]. Russ J Econ, 2017, 3(3): 296-320.

21.Wu L, Huang Z, Pan Z. The spatiality and driving forces of population ageing in China[J]. PLoS One, 2021, 16(1): e0243559.

22.Ju W, Zheng R, Wang S, et al. The occurence of cancer in ageing populations at global and regional levels, 1990 to 2019[J]. Age Ageing, 2023, 52(9): afad043.

23.Hitoshi M, Kazuhiro G, Sakae T, et al. Narrow band imaging technique[J]. Tech Gastrointest Endosc, 2003, 5(2): 78-81.

24.Agostino G, Francesco P, Marco A, et al. A practical guide to the use of Narrow Band Imaging (NBI) in the early detection of oral cancer: case series and review of the literature[J]. J Oral Med Oral Surghttps://xueshu.baidu.com/ndscholar/browse/detail?paperid=1s4a06d0096t06f0uc790c403b117676, 2025, 31(1): 3.

25.Lipsky MS, Su S, Crespo CJ, et al. Men and oral health: a review of sex and gender differences[J]. Am J Mens Health, 2021, 15(3): 15579883211016361.

26.Conway DI, Hovanec J, Ahrens W, et al. Occupational socioeconomic risk associations for head and neck cancer in Europe and South America: individual participant data analysis of pooled case–control studies within the INHANCE Consortium[J]. J Epidemiol Community Health, 2021, 75(8): 779-787.

27.Tarvainen L, Suojanen J, Kyyronen P, et al. Occupational risk for oral cancer in Nordic countries[J]. Anticancer Res, 2017, 37(6): 3221-3228.

28.World Health Organization. WHO global report on trends in prevalence of tobacco use 2000-2025[EB/OL]. (2021)[2026-02-01]. https://iris.who.int/handle/10665/348537https://iris.who.int/handle/10665/348537.

29.Liu S, Zhang M, Yang L, et al. Prevalence and patterns of tobacco smoking among Chinese adult men and women: findings of the 2010 national smoking survey[J]. J Epidemiol Community Health, 2017, 71(2): 154-161.

30.Ng R, Sutradhar R, Yao Z, et al. Smoking, drinking, diet and physical activity-modifiable lifestyle risk factors and their associations with age to first chronic disease[J]. Int J Epidemiol, 2020, 49(1): 113-130.

31.Karan A, Negandhi H, Nair R, et al. Size, composition and distribution of human resource for health in India: new estimates using National Sample Survey and Registry data[J]. BMJ Open, 2019, 9(4): e025979.

32.Oshima K, Miura H, Tano R, et al. Characteristics of individuals in Japan who regularly manage their oral health by having a family dentist: a nationwide cross-sectional web-based survey[J]. Int J Environ Res Public Health, 2022, 19(17): 10479.

33.Petersen PE, Baez RJ, Ogawa H. Global application of oral disease prevention and health promotion as measured 10 years after the 2007 World Health Assembly statement on oral health[J]. Community Dent Oral Epidemiol, 2020, 48(4): 338-348.

34.Akashanand, Zahiruddin QS, Jena D, et al. Burden of oral cancer and associated risk factors at national and state levels: a systematic analysis from the global burden of disease in India, 1990-2021[J]. Oral Oncol, 2024, 159: 107063.

35.Yuwanati M, Sarode SC, Gadbail A, et al. Modern lifestyle, stress and metabolism: possible risk factors for oral carcinogenesis in the young generation[J]. Future Oncol, 2022, 18(15): 1801-1804.

Popular Papers